Skip to main content

Laxatives Cure Bed-Wetting for Many Children

January 31, 2012 — Laxatives are the answer for many children experiencing bed-wetting, according to a report from Wake Forest University in Winston-Salem, North Carolina. Investigators report that occult megarectum is a commonly overlooked cause of nocturnal enuresis, and that it can be detected simply by an abdominal X-ray and treated with laxatives.
Lead author Steve Hodges, MD, assistant professor of urology, and coauthor Evelyn Anthony, MD, from the Department of Radiology at the university, found that 30 children and adolescents aged 5 to 15 years seeking treatment for bed-wetting had large amounts of stool in their rectums, even though they reported having normal bowel habits. The report, published online December 14 in Urology, showed that 3 months of laxative therapy cured 25 patients (83%) of their bed-wetting.
The authors note that stool retention reduces bladder capacity (and possibly leads to bladder overactivity) and explains why many therapies aimed at the bladder, such as fluid restriction or alarms, may be ineffective.
A landmark study performed more than 25 years ago showed that constipation, defined as abnormal rectal distension, was a commonly unrecognized cause of enuresis. However, those findings did little to change practice. This definition of constipation differs from that of the International Children's Continence Society (ICCS) guidelines, which rely on bowel habits and stool consistency. The researchers hypothesized that undiagnosed megarectum underlies many cases of nocturnal enuresis, and that laxative treatment may be effective.
They performed a retrospective review of 30 consecutive patients (19 boys and 11 girls) seen in their clinic who presented with a chief complaint of nighttime enuresis. They used a novel method to determine the rectal/pelvic outlet ratio and the Leech criteria for assessing fecal loading, using a plain abdominal radiograph, and compared these findings with the reported constipation history according to the ICCS guidelines. According to the guidelines, a diagnosis of constipation is made based on parents' and children's reports of a bowel movement less frequently than every other day, and on whether the stool consistency is hard.
The rectal/pelvic outlet ratio is the ratio of the maximum diameter of the rectum when distended by stool, divided by the diameter of the pelvic outlet between the obturator stripes at the level of the femoral heads.
All the patients showed rectal distension, based on a rectal/pelvic ratio greater than 1, and 80% met the Leech criteria for constipation. Only 3 of the children or families (10%) described bowel habits consistent with constipation. There was a statistically significant difference between the radiographic findings for fecal loading by the Leech criteria and self-reported constipation (P < .001), with the radiographic findings revealing otherwise unknown constipation. For example, for 27 cases in which the self-reports were negative, radiographs showed constipation in 21.
Initial therapy was a bowel clean-out with polyethylene glycol 3350 laxative (PEG), followed by a daily maintenance dose "titrated to keep the stools the consistency of a milk shake," the authors write. If follow-up imaging at 1 and 3 months showed persistent megarectum, daily phosphate enemas or stimulant laxatives were added to the PEG regimen.
The researchers reported that all of the 4 adolescents and 80% of the younger children in the study were cured of their enuresis by these methods. Persistent enuresis at 3 months with no rectal stool on X-ray was considered a treatment failure.
Because some of the cases may have improved over time on their own, a more rigorous test of the efficacy of laxative therapy would require a randomized trial assigning some constipated children to the therapy and others to an inactive therapy, Dr. Hodges noted in a press release from Wake Forest University. He also advised that any medical therapy for bed-wetting be done under the supervision of a physician.
Proper treatment in many cases may require the recognition of occult megarectum, and physicians would do well to focus on rectal distension, and not just functional constipation. In addition to X-ray, Dr. Hodges suggested, in the press release, that rectal distension could also be determined using rectal ultrasonography, with the advantage of avoiding ionizing radiation. He emphasized the importance of a correct diagnosis to avoid unnecessary surgery and the adverse effects of medication (such as desmopressin), and he urged physicians to first obtain an X-ray or ultrasound.
Dr. Hodges has disclosed no relevant financial relationships

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n